Рет қаралды 711
Conversation around specific cardiovascular risks, while distinguishing between glycemic control and cardiovascular risk reduction. We will also highlight the benefits of treatment with GLP-1 RA in patients with diabetes.
Claim CE and MOC Credit at bit.ly/4aKSocQ